A scattered session with weight in biotech and semiconductors, while crypto and macro commentary shifted positioning. No unified market direction; sectoral moves dominated.

• Moderna doubles after Phase 3 cancer-vaccine trial beats standard of care
• Broadcom raises tens of billions in debt for chip deal financing
• Dalio warns of debt crisis, tilts toward Bitcoin and gold over bonds
• Solana cuts block-production window, first reduction since network launch
• Samsung announces shareholder returns including third-quarter dividend payout

Sources: The Block, CNBC, Decrypt, Cointelegraph, MarketWatch, CoinDesk, The Defiant

This article is for information only and is not financial advice.